Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
CA Stock MarketDetailed Quotes
CRDL Cardiol Therapeutics Inc
- 1.590
- +0.100+6.71%
15min DelayMarket Closed Apr 29 16:00 ET
131.35MMarket Cap-3.12P/E (TTM)
1.630High1.470Low167.30KVolume1.490Open1.490Pre Close263.47KTurnover4.26052wk High0.21%Turnover Ratio82.61MShares1.09052wk Low-0.51EPS TTM125.14MFloat Cap8.490Historical HighLossP/E (Static)78.71MShs Float0.610Historical Low-0.51EPS LYR10.74%Amplitude--Dividend TTM5.32P/B1Lot Size--Div YieldTTM
About Cardiol Therapeutics Inc Company
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
Company Profile
SymbolCRDL
Company NameCardiol Therapeutics Inc
Founded2017
MarketTSE
Employees22
Fiscal Year Ends12-31
Address2265 Upper Middle Road East Suite 602
CityOakville
CountryCAN
Zip CodeL6H 0G5
Phone+1 289 910-0850
Websitehttps://www.cardiolrx.com
Company Executives
- Name
- Position
- Salary
- David G. Elsley
- Director, President and Chief Executive Officer
- 748.10K
- Christopher J. Waddick, C.A.,C.P.A.
- Director, Chief Financial Officer and Corporate Secretary
- 294.80K
- Bernard Lim
- Chief Operating Officer
- 515.90K
- Dr. Andrew Hamer, M.D.
- Chief Medical Officer and Head, Research and Development
- 746.56K
- Dr. Guillermo Torre-Amione, M.D.,PhD
- Chairman of the Board
- 112.68K
- Teri Loxam
- Independent Director
- 82.32K
- Jennifer Chao
- Independent Director
- 76.92K
- Peter Pekos
- Independent Director
- 58.00K
- Michael J. Willner
- Independent Director
- 71.52K
- Colin G. Stott
- Independent Director
- 60.00K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts